Tradestie Institutional Equity Comparison Engine
INCY vs VRTX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
VRTX Overall Edge
VRTX Captures Institutional Edge (4โ0 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vertex Pharmaceuticals Inc (VRTX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, INCY trades at 14.0x Forward P/E with 32.2% operating margin (+14.0% YoY revenue) versus VRTX at 27.0x Forward P/E and 37.8% operating margin (+11.8% YoY). In options structure, INCY sits in CONSOLIDATION (64th %ile IV; Dealer Gamma Walls on Pro) against VRTX sits in CONSOLIDATION (25th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
VRTX
INCY 14.0x vs VRTX 27.0x Fwd P/E
Growth & Margin Winner
VRTX
Op Margin 32.2% vs 37.8% ยท YoY +14.0% vs +11.8%
Momentum & Technical Winner
VRTX
1Y +13.7% vs +23.2% ยท 52W Pos 71% vs 79%
Options & Structure Winner
VRTX
CONSOLIDATION (64th %ile IV) vs CONSOLIDATION (25th %ile IV)
INCY
NASDAQ
Incyte Genomics Inc
Services-Commercial Physical & Biological Research
$119.86
-0.92% 1D
Market Cap
$24.8B
1M Return
+6.01%
1Y Return
+13.71%
Forward P/E
14.0x
Unified AI Score
61.2 / 100
BUY
Tech 45.0
Fund 56.0
Flow 68.0
Mom 60.0
VRTX
NASDAQ
Vertex Pharmaceuticals Inc
Pharmaceutical Preparations
$535.27
-0.62% 1D
Market Cap
$137.6B
1M Return
+7.11%
1Y Return
+23.19%
Forward P/E
27.0x
Unified AI Score
37.0 / 100
SELL
Tech 39.0
Fund 48.0
Flow 70.0
Mom 31.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
INCY +13.71%
VRTX +23.19%
Spread: +9.48 pp (VRTX Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | INCY Revenue | VRTX Revenue | INCY Op. Margin | VRTX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $1.88B | $3.05B | 6.9% | 20.8% | VRTX |
| FY2019 | $2.16B | $4.16B | 18.6% | 28.8% | VRTX |
| FY2020 | $2.67B | $6.21B | -9.9% | 46.0% | VRTX |
| FY2021 | $2.99B | $7.57B | 19.6% | 36.7% | VRTX |
| FY2022 | $3.39B | $8.93B | 17.1% | 48.2% | VRTX |
| FY2023 | $3.70B | $9.87B | 16.8% | 38.8% | VRTX |
| FY2024 | $4.24B | $11.0B | 1.4% | -2.1% | INCY |
| FY2025 | $5.14B | $12.0B | 29.5% | 34.8% | VRTX |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | INCY | VRTX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $24.8B | $137.6B | Larger Scale | VRTX |
| Trailing P/E Ratio Valuation | 62.1x | 34.9x | Lower Multiple | VRTX |
| Forward P/E Ratio Valuation | 14.0x | 27.0x | Lower Multiple | INCY |
| Revenue Growth (YoY) Growth | +14.0% | +11.8% | Higher Growth | INCY |
| Operating Margin (TTM) Profitability | 32.2% | 37.8% | Higher Margin | VRTX |
| Net Profit Margin Profitability | 6.7% | 30.7% | Higher Margin | VRTX |
| Return on Equity (ROE) Capital Efficiency | 7.8% | 20.8% | Higher ROE | VRTX |
| 52-Week Range Position Momentum | 71% ($89โ$133) | 79% ($412โ$569) | Stronger Trend | VRTX |
| Beta / 30D Volatility Risk Regime | 0.30ฮฒ ยท 35% Vol | 0.36ฮฒ ยท 30% Vol | Lower Realized Risk | VRTX |
| Unified Institutional Score Composite Signal | 61.2 / 100 (BUY) | 37.0 / 100 (SELL) | Higher Composite | INCY |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full INCY vs VRTX Buy Guide
INCY
CONSOLIDATION
78d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
64th %ile
IV Regime
Elevated (60thโ80th %ile)
VRTX
CONSOLIDATION
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
25th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither INCY nor VRTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.